Should I Buy SNYR? SNYR 2026 Analysis

Should You Buy Synergy CHC Corp (SNYR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

1.840

1 Day change

1.10%

52 Week Range

4.460

Analysis Updated At

2026/01/26

Synergy CHC Corp (SNYR) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown revenue growth and improved gross margins, its net income and EPS have significantly declined. Additionally, there are no strong trading signals or recent positive news to suggest immediate upside potential. The stock's technical indicators are neutral, and the lack of significant trading trends or political activity further supports a cautious approach.

Technical Analysis

The MACD is positive and expanding, suggesting a mild bullish trend. RSI is neutral at 56.643, and moving averages are converging, indicating no clear direction. Key support and resistance levels are Pivot: 1.858, R1: 1.986, S1: 1.729, R2: 2.065, S2: 1.65. Overall, the technical indicators do not provide a strong buy signal.

Options Data

Positive Catalysts

Gross margin improved to 70.5%, up 5.62% YoY. Analyst Sean McGowan maintains a Buy rating and highlights the company's potential for significant growth in 2026 due to its recent equity raise.

Neutral/Negative Catalysts

The company faced cash constraints prior to its equity raise. No recent news or significant trading trends from hedge funds, insiders, or politicians.

Financial Performance

In Q3 2025, revenue grew by 12.40% YoY to $8,010,112. However, net income declined sharply by 84.01% YoY to $125,327, and EPS dropped by 90.00% YoY to $0.01. Gross margin improved to 70.5%, up 5.62% YoY, indicating better operational efficiency despite profitability challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Roth Capital analyst Sean McGowan lowered the price target from $10 to $7 but maintained a Buy rating. The analyst cited progress in distribution and geographic expansion but noted challenges due to prior cash constraints. The recent equity raise is expected to enable significant growth in 2026.

1 Analyst Rating

Wall Street analysts forecast SNYR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNYR is 7 USD with a low forecast of 7 USD and a high forecast of 7 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 1.820

Low

Averages

High

Current: 1.820

Low

Averages

High

Roth Capital

Sean McGowan

Buy

downgrade

$10 -> $7

AI Analysis

2025-11-14

Reason

Roth Capital

Sean McGowan

Price Target

$10 -> $7

AI Analysis

2025-11-14

downgrade

Buy

Reason

Roth Capital analyst Sean McGowan lowered the firm's price target on Synergy CHC to $7 from $10 and keeps a Buy rating on the shares. The company made good progress during Q3, broadening its distribution footprint for both supplements and beverages and continuing to expand geographically, though its results came up short of expectations due in part to cash being tight prior to the company's recent equity raise, the analyst tells investors in a research note. Roth adds however that Synergy now has the capital needed to post significant growth in 2026.

SNYR Should I Buy

SNYR Should I Buy

Should You Buy Synergy CHC Corp (SNYR) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch